Steve Hill

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Steve Hill's trades of Cellectar Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
74.10
Quantity 34,722 +32.0%
Value US$48,323
Transaction date
Sale
Price
169.95
Quantity 90,173 +43.0%
Value US$2,935,328
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
135.33
Quantity 55,606 -36.2%
Value US$2,984,576
US Lipocine Inc (LPCN)
Transaction date
Purchase
Price
4.95
Quantity 4,000 +inf%
Value US$19,800
Transaction date
Purchase
Price
3.75
Quantity 5,300 +inf%
Value US$19,875
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-30 2018-11-29
S Sale
34,722 +32.0%
74.10
US$48,323 		34,722 +32.0% 74.10 US$48,323
2018-11-30 2018-11-29
S Sale
90,173 +43.0%
169.95
US$2,935,328 		90,173 +43.0% 169.95 US$2,935,328
2018-01-02 2017-12-29
US Lipocine Inc (LPCN)
PlS Planned sale
55,606 -36.2%
135.33
US$2,984,576 		55,606 -36.2% 135.33 US$2,984,576
2014-11-13 2014-11-13
US Lipocine Inc (LPCN)
B Purchase
4,000 +inf%
4.95
US$19,800 		4,000 +inf% 4.95 US$19,800
2014-08-22 2014-08-20
B Purchase
5,300 +inf%
3.75
US$19,875 		5,300 +inf% 3.75 US$19,875